Gentherm (THRM) Q3 2026 Earnings Call Transcript
Gentherm (THRM) reported Q3 2026 earnings, highlighting growth in automotive, power generation, and commercial vehicles. The company aims for $3.5B revenue and $500M EBITDA by 2030. It secured $555M in new business awards and launched new products like the Puls.A massage system. Gentherm also expanded into India and the medical market through acquisitions.
How this was made

The 30-second read
Why it matters
The disclosed numbers and strategic moves provide fresh material that could move the stock.
Market read
Earnings beat and acquisition deliver new growth narrative, likely prompting trader interest.
What to watch
Integration risks of Modine merger and execution of medical acquisition could temper upside.
Background
Gentherm's Q3 2026 earnings call covered revenue growth, new automotive awards, product launches, and the acquisition of Innovative Medical Equipment.
Ticker impact
Gentherm disclosed Q3 revenue up 4.7% YoY, new automotive awards of $555M and announced acquisition of Innovative Medical Equipment, providing fresh guidance to $3.5B revenue by 2030.
likely upward pressure as market prices in stronger guidance and acquisition synergies
Guidance exceeds prior expectations; acquisition expands medical segment, both are material new information.
Market effects
Automotive thermal management and medical thermal therapy sectors may see increased investor interest.
India market exposure highlighted; could boost sentiment toward Indian automotive suppliers.
Gentherm's diversification may influence broader thermal management industry valuations.
Counterpoint
Guidance may be optimistic given macro headwinds and material cost inflation.
Key entities
- CompanyGentherm
Thermal management solutions provider (ticker THRM).
- CompanyInnovative Medical Equipment
Acquired medical device firm expanding Gentherm's medical portfolio.



